Precision BioSciences, Inc. (DTIL) — Financial statements
Income statement, balance sheet, and cash flow for Precision BioSciences, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 34↓50.1% | 69↑41.0% | 49↑94.1% | 25↓78.3% | 116 | |
| Cost of Revenue | 3 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Gross Profit | 32↓54.1% | 69↑41.0% | 49↑94.1% | 25↓78.3% | 116 | |
| Operating Expenses | ||||||
| R&D Expenses | 54↓9.0% | 60↑11.6% | 53↑15.7% | 46↓60.0% | 115 | |
| General & Administrative Expenses | 32↓8.7% | 35↓9.7% | 39↓5.3% | 41↑4.1% | 40 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 32↓8.7% | 35↓9.7% | 39↓5.3% | 41↑4.1% | 40 | |
| Other Expenses | -3 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | 84↓11.8% | 95↑2.6% | 92↑5.8% | 87↓43.6% | 155 | |
| Total Costs & Expenses | 86↓8.9% | 95↑2.6% | 92↑5.8% | 87↓43.6% | 155 | |
| Operating Results | ||||||
| Operating Income | -52↓99.3% | -26↑40.2% | -44↑29.8% | -62↓58.2% | -39 | |
| Depreciation & Amortization | 3↓39.9% | 5↓44.6% | 8↓8.3% | 9↓11.7% | 10 | |
| EBITDA | -49↓465.2% | 14↑142.2% | -32↑49.0% | -63↓209.7% | -20 | |
| EBIT | -52↓682.7% | 9↑122.2% | -40↑43.9% | -72↓135.6% | -30 | |
| Interest & Other Income | ||||||
| Net Interest Income | 3↓43.4% | 5↓8.7% | 5↑131.0% | 2↑3007.9% | 0.08 | |
| Interest Income | 4↓37.3% | 7↓12.0% | 8↑121.3% | 3↑1569.7% | 0.21 | |
| Interest Expense | 1↓20.2% | 2↓20.1% | 2↑100.7% | 1↑741.7% | 0.13 | |
| Non-Operating Income | 0.00↑100.0% | -35↓921.0% | -3↓136.2% | 9↑206.6% | -9 | |
| Other Income / Expenses | 6↓83.4% | 33↑2656.7% | 1↑111.4% | -11↓220.8% | 9 | |
| Income Before Tax | -47↓750.3% | 7↑116.9% | -43↑41.7% | -73↓138.2% | -31 | |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -47↓750.3% | 7↑116.9% | -43↑41.7% | -73↓138.2% | -31 | |
| Net Income from Discontinued Operations | 0.00 | 0.00↑100.0% | -19↑51.5% | -39 | 0.00 | |
| Net Income | -47↓750.3% | 7↑111.7% | -61↑45.1% | -112↓264.8% | -31 | |
| Bottom-Line Net Income | -47↓750.3% | 7↑111.7% | -61↑45.1% | -112↓264.8% | -31 | |
| EPS (Basic) | -3.63↓445.7% | 1.05↑106.6% | -15.96↑58.1% | -38.10↓144.2% | -15.60 | |
| EPS (Diluted) | -3.63↓449.0% | 1.04↑106.5% | -15.96↑58.1% | -38.10↓144.2% | -15.60 | |
| Weighted Average Shares | 13↑87.7% | 7↑77.9% | 4↑31.1% | 3↑49.8% | 2 | |
| Weighted Average Diluted Shares | 13↑86.3% | 7↑79.2% | 4↑31.1% | 3↑49.8% | 2 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.